Unique ID issued by UMIN | UMIN000035411 |
---|---|
Receipt number | R000040347 |
Scientific Title | Assessment of the temperature of the central and peripheral ablation area induced by a new microwave ablation system and radiofrequency ablation system for the liver cancer |
Date of disclosure of the study information | 2019/01/07 |
Last modified on | 2018/12/30 10:41:30 |
Assessment of the temperature of the central and peripheral ablation area induced by a new microwave ablation system and radiofrequency ablation system for the liver cancer
Assessment of the temperature the central and peripheral ablation area induced by local therapy for the liver cancer
Assessment of the temperature of the central and peripheral ablation area induced by a new microwave ablation system and radiofrequency ablation system for the liver cancer
Assessment of the temperature the central and peripheral ablation area induced by local therapy for the liver cancer
Japan |
Patients with liver cancer that the local therapy is possible
Hepato-biliary-pancreatic medicine |
Malignancy
NO
A new system for microwave ablation can generate a large and spherical ablation zone. However, due to its characteristics, there is a possibility that heat is transferred to the surrounding non-target organ. In this study, the temperature of the central and peripheral ablation area obtained by the microwave system and the conventional radiofrequency wave ablation therapy are measured, and the spread of heat to peripheral organs is examined.
Safety
The temperature of the central and peripheral ablation area induced by a new microwave ablation system and radiofrequency ablation system for the liver cancer
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
2
Diagnosis
Maneuver |
The temperature measurement using by a temperature sensor for microwave ablation
The temperature measurement using by a temperature sensor for radiofrequecy ablation
20 | years-old | <= |
90 | years-old | >= |
Male and Female
Inclusion criteria for patients with HCC were as follows: the presence of a potentially curable liver-confined disease and disease unsuitable to hepatic resection alone because of inadequate functional liver reserve. All the patients with HCC presented with different degrees of cirrhosis, with Child-Pugh class A or B. Inclusion criteria for patients with liver metastases were: curative intent of liver-confined disease, and contraindication to surgery and local liver disease control when other treatments such as radiotherapy or chemotherapy were applied to extrahepatic tumor sites.
The exclusion criteria for patients were: age < 19 years; known or suspected pregnancy; abnormal results of a serological coagulation screen; or tumor not accessible percutaneously.
20
1st name | |
Middle name | |
Last name | KENTO IMAJO |
Yokohama City University Graduate School of Medicine
Department of Gastroenterology and Hepatology
3-9 Fukuura, Kanazawa-ku, yokohama city
+81-45-787-2640
kento318@yokohama-cu.ac.jp
1st name | |
Middle name | |
Last name | KENTO IMAJO |
Yokohama City University Graduate School of Medicine
Department of Gastroenterology and Hepatology
3-9 Fukuura, Kanazawa-ku, yokohama city
+81-45-787-2640
kento318@yokohama-cu.ac.jp
Yokohama City University Graduate School of Medicine
Yokohama City University Graduate School of Medicine
Self funding
NO
2019 | Year | 01 | Month | 07 | Day |
Unpublished
Open public recruiting
2018 | Year | 12 | Month | 01 | Day |
2018 | Year | 12 | Month | 17 | Day |
2018 | Year | 12 | Month | 30 | Day |
2018 | Year | 12 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040347